MedPath

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Phase 3
Recruiting
Conditions
Colonic Neoplasms
Interventions
Procedure: Japanese pathological investigation
Procedure: European pathological investigation
Registration Number
NCT06119867
Lead Sponsor
Russian Society of Colorectal Surgeons
Brief Summary

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
430
Inclusion Criteria
  • Patients diagnosed with colon cancer who underwent colectomy;
  • Patients with pathological confirmed adenocarcinoma;
  • Patients agreed to participate in the study.
Exclusion Criteria
  • Patients suffered from rectal cancer;
  • Patients diagnosed with colon cancer but did not undergo colectomy;
  • Patients refused participation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Japanese pathological investigation method groupJapanese pathological investigationThe surgeon will be involved into the Japanese pathological investigation method. The surgeon will perform the intraoperative markings and the postoperative lymph node harvest, after which the specimen will be assessed by the pathologist.
European pathological investigation method groupEuropean pathological investigationAfter receiving the resected specimen, the entire process will be independently managed by the pathologist.
Primary Outcome Measures
NameTimeMethod
Comparision of the incidence of stage III colon cancer between European and Japanese pathological investigation methods.up to 24 months

indentification of the rate of postive lymph nodes

Secondary Outcome Measures
NameTimeMethod
The role of immunohistochemical examination in the Node (N) stage determinationup to 24 months

indentification of the rate of postive lymph nodes using immunohistochemical examination

Comparison of the resection margin (proximal, distal, circular) between the European and Japanese pathological approachesup to 24 months

indentification of the rate of the postive proximal, distal or circular resection margin

Comparison of the lymph node ratio (LNR) between the European and Japanese pathological approachesup to 24 months

LNR=Postivie lymph node/ Total retrived lymph node

Comparison of the tumor budding between the European and Japanese pathological approachesup to 24 months

indentification of the rate of tumor budding

Comparison of the tumor-infiltrating lymphocytes (TIL) count between the European and Japanese pathological approachesup to 24 months

indentification of the rate of the tumor-infiltrating lymphocytes (TIL) count

Comparison of the pT Stage between the European and Japanese pathological approachesup to 24 months

indentification of the rate of the pathological T stages

Comparison of the extracapsular invasion between the European and Japanese pathological approachesup to 24 months

indentification of the rate of the extracapsular invasion

Comparison of the extramural invasion (venous, lymphatic, perineural) between the European and Japanese pathological approachesup to 24 months

indentification of the rate of the venous, lymphatic or perineural extramural invasion

Trial Locations

Locations (1)

Clinic of coloproctology and minimally invasive surgery

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath